Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. Teva Pharmaceuticals USA Inc
CRL
•Teva Pharmaceuticals USA Inc

Teva Pharmaceuticals USA Inc – FDA CRL

Record Details

The FDA issued a Complete Response Letter (CRL) to Teva Pharmaceuticals USA regarding their New Drug Application (NDA 208574) for Romidepsin Injection, 10 mg/2 mL, submitted under section 505(b)(2). The application was not approved due to several outstanding issues.

Primary concerns include product quality deficiencies, specifically an inadequate rationale for potential extractables and leachables from the drug's container system under proposed manufacturing conditions. Teva is required to provide comprehensive data and study results to address this. Significant revisions are also mandated for the proposed prescribing information, which contains error-prone symbols and requires phrasing corrections to align with FDA labeling regulations. Carton and container labeling also needs updates, including the addition of quantitative ingredient and sterility information, and clearer presentation of critical dilution instructions.

Additionally, a recent inspection of Teva Pharmaceutical Works Private Limited Company's manufacturing facility in Gödöllő, Hungary, revealed deficiencies that must be satisfactorily resolved. Teva must also submit a comprehensive safety update, incorporating all new clinical and nonclinical data, detailed safety profile changes, updated exposure information, and worldwide safety experience. Teva is required to fully address all deficiencies within one year for the application to be reconsidered for approval.

Company
Teva Pharmaceuticals USA Inc
Product type
Drugs
Office
Division of Hematology Products
Person
  • Cory Wohlbach
View Company Profile

ID · 8064914f-72ef-45b5-92cb-05db49d589dc

Other documents for Teva Pharmaceuticals USA Inc
  • CRL
  • CRL

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva Pharmaceuticals USA Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.